Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	BROMODOMAIN_1	ASH1L BRDT BAZ1A TAF1L	1.65e-04	37	140	4	PS00633
Domain	CK1gamma_C	CSNK1G2 CSNK1G3	1.67e-04	3	140	2	PF12605
Domain	Casein_kinase-1_gamma_C	CSNK1G2 CSNK1G3	1.67e-04	3	140	2	IPR022247
Domain	Bromodomain	ASH1L BRDT BAZ1A TAF1L	1.83e-04	38	140	4	PF00439
Domain	SH3_1	ABI3 SPTAN1 EPS8L1 NEB ARHGAP12 DLG4 FUT8	2.39e-04	164	140	7	PF00018
Domain	BROMODOMAIN_2	ASH1L BRDT BAZ1A TAF1L	2.47e-04	41	140	4	PS50014
Domain	Bromodomain	ASH1L BRDT BAZ1A TAF1L	2.71e-04	42	140	4	IPR001487
Domain	BROMO	ASH1L BRDT BAZ1A TAF1L	2.71e-04	42	140	4	SM00297
Domain	-	ASH1L BRDT BAZ1A TAF1L	2.71e-04	42	140	4	1.20.920.10
Domain	ATP_Ca_trans_C	ATP2B3 ATP2B4	3.31e-04	4	140	2	IPR022141
Domain	Sec63	HFM1 SNRNP200	3.31e-04	4	140	2	PF02889
Domain	Sec63	HFM1 SNRNP200	3.31e-04	4	140	2	SM00973
Domain	ATP_Ca_trans_C	ATP2B3 ATP2B4	3.31e-04	4	140	2	PF12424
Domain	Sec63-dom	HFM1 SNRNP200	3.31e-04	4	140	2	IPR004179
Domain	Argonaute_N	AGO1 AGO3	3.31e-04	4	140	2	IPR032474
Domain	Argonaute_Mid_dom	AGO1 AGO3	3.31e-04	4	140	2	IPR032473
Domain	ArgoL2	AGO1 AGO3	3.31e-04	4	140	2	IPR032472
Domain	P-type_ATPase_IIB	ATP2B3 ATP2B4	3.31e-04	4	140	2	IPR006408
Domain	ArgoN	AGO1 AGO3	3.31e-04	4	140	2	PF16486
Domain	ArgoMid	AGO1 AGO3	3.31e-04	4	140	2	PF16487
Domain	ArgoL2	AGO1 AGO3	3.31e-04	4	140	2	PF16488
Domain	DUF1785	AGO1 AGO3	5.50e-04	5	140	2	SM01163
Domain	CP2	TFCP2 TFCP2L1	8.20e-04	6	140	2	PF04516
Domain	CP2	TFCP2 TFCP2L1	8.20e-04	6	140	2	IPR007604
Domain	ArgoL1	AGO1 AGO3	8.20e-04	6	140	2	PF08699
Domain	ArgoL1	AGO1 AGO3	8.20e-04	6	140	2	IPR014811
Domain	Bromodomain_CS	BRDT BAZ1A TAF1L	9.45e-04	26	140	3	IPR018359
Domain	SH3	ABI3 SPTAN1 EPS8L1 NEB ARHGAP12 DLG4 FUT8	1.23e-03	216	140	7	SM00326
Domain	SH3	ABI3 SPTAN1 EPS8L1 NEB ARHGAP12 DLG4 FUT8	1.23e-03	216	140	7	PS50002
Domain	Helicase_C	HELQ HFM1 MTREX SNRNP200 HELLS	1.27e-03	107	140	5	PF00271
Domain	HELICc	HELQ HFM1 MTREX SNRNP200 HELLS	1.27e-03	107	140	5	SM00490
Domain	Helicase_C	HELQ HFM1 MTREX SNRNP200 HELLS	1.32e-03	108	140	5	IPR001650
Domain	SH3_domain	ABI3 SPTAN1 EPS8L1 NEB ARHGAP12 DLG4 FUT8	1.37e-03	220	140	7	IPR001452
Domain	HELICASE_CTER	HELQ HFM1 MTREX SNRNP200 HELLS	1.38e-03	109	140	5	PS51194
Domain	HELICASE_ATP_BIND_1	HELQ HFM1 MTREX SNRNP200 HELLS	1.38e-03	109	140	5	PS51192
Domain	DEXDc	HELQ HFM1 MTREX SNRNP200 HELLS	1.38e-03	109	140	5	SM00487
Domain	Helicase_ATP-bd	HELQ HFM1 MTREX SNRNP200 HELLS	1.44e-03	110	140	5	IPR014001
Domain	DAD_dom	DIAPH3 FMNL1	1.52e-03	8	140	2	IPR014767
Domain	PIWI	AGO1 AGO3	1.52e-03	8	140	2	PS50822
Domain	Piwi	AGO1 AGO3	1.52e-03	8	140	2	SM00950
Domain	DAD	DIAPH3 FMNL1	1.52e-03	8	140	2	PS51231
Domain	Piwi	AGO1 AGO3	1.52e-03	8	140	2	PF02171
Domain	Piwi	AGO1 AGO3	1.52e-03	8	140	2	IPR003165
Domain	PAZ	AGO1 AGO3	1.94e-03	9	140	2	PS50821
Domain	Drf_GBD	DIAPH3 FMNL1	1.94e-03	9	140	2	PF06371
Domain	Drf_FH3	DIAPH3 FMNL1	1.94e-03	9	140	2	PF06367
Domain	PAZ	AGO1 AGO3	1.94e-03	9	140	2	SM00949
Domain	PAZ	AGO1 AGO3	1.94e-03	9	140	2	PF02170
Domain	FH3_dom	DIAPH3 FMNL1	1.94e-03	9	140	2	IPR010472
Domain	GTPase-bd	DIAPH3 FMNL1	1.94e-03	9	140	2	IPR010473
Domain	Drf_FH3	DIAPH3 FMNL1	1.94e-03	9	140	2	SM01139
Domain	PAZ_dom	AGO1 AGO3	1.94e-03	9	140	2	IPR003100
Domain	Drf_GBD	DIAPH3 FMNL1	1.94e-03	9	140	2	SM01140
Domain	MAGE	MAGEA1 MAGEB2 MAGED2	2.08e-03	34	140	3	SM01373
Domain	DEAD/DEAH_box_helicase_dom	HELQ HFM1 MTREX SNRNP200	2.21e-03	73	140	4	IPR011545
Domain	DEAD	HELQ HFM1 MTREX SNRNP200	2.21e-03	73	140	4	PF00270
Domain	MAGE	MAGEA1 MAGEB2 MAGED2	2.46e-03	36	140	3	PS50838
Domain	MHD_dom	MAGEA1 MAGEB2 MAGED2	2.46e-03	36	140	3	IPR002190
Domain	MAGE	MAGEA1 MAGEB2 MAGED2	2.46e-03	36	140	3	PF01454
Domain	FN3	COL12A1 CMYA5 GHR PTPRD MDGA1 MYBPC1	2.73e-03	185	140	6	SM00060
Domain	SH3_9	ABI3 NEB ARHGAP12 FUT8	2.81e-03	78	140	4	PF14604
Domain	GBD/FH3_dom	DIAPH3 FMNL1	2.94e-03	11	140	2	IPR014768
Domain	BAH	MTA2 ASH1L	2.94e-03	11	140	2	PS51038
Domain	GBD_FH3	DIAPH3 FMNL1	2.94e-03	11	140	2	PS51232
Domain	BAH_dom	MTA2 ASH1L	2.94e-03	11	140	2	IPR001025
Domain	BAH	MTA2 ASH1L	2.94e-03	11	140	2	SM00439
Domain	BAH	MTA2 ASH1L	2.94e-03	11	140	2	PF01426
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	MTA2 FLNA ACACA ATR SPTAN1 UGGT1 RTN3 CMYA5 TFCP2 POLR3A EEF1A1 SCAF1 RPS26P11 IPO9 ADSS2 MAGED2 BAZ1A MTREX ATP2B3 SNRNP200 CAP1 MGAM2 MYBPC1 HELLS	8.64e-09	1425	148	24	30948266
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ZHX3 MXRA5 NAP1L3 ALG11 NEB RYR2 NDUFV2 IPO9 PI4KB VPS13A HFM1 WDR17 ATP2B3 KNL1 DNAH11 HELLS	1.59e-08	638	148	16	31182584
Pubmed	Defining the membrane proteome of NK cells.	MTA2 FLNA ACAP1 ABI3 DOCK8 KATNB1 ALG11 ECE1 ITGAX LRRC8D POLR3A EEF1A1 ERGIC1 IPO9 AGO3 MAGED2 PLXNC1 CSNK1G2 FUT8 ATP2B4 FMNL1	2.71e-08	1168	148	21	19946888
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	FLNA IQGAP2 SPTAN1 UGGT1 ASH1L FAM47B CFAP210 NEB ECE1 RYR2 NDUFV2 EEF1A1 ACSM3 MAGED2 BAZ1A FAM186A ARHGAP12 VPS13A DIAPH3 ATP2B3 MYBPC1	8.80e-07	1442	148	21	35575683
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	MTA2 FLNA IQGAP2 SPTAN1 UGGT1 PEG3 LARP1B TTF1 TFCP2 EEF1A1 SCAF1 IPO9 AGO3 MAGED2 BAZ1A EHHADH MTREX METAP2 ATP2B4 CPNE7	1.60e-06	1371	148	20	36244648
Pubmed	Functional proteomics mapping of a human signaling pathway.	FLNA ANK3 DOCK8 ASH1L TTF1 RYR2 EEF1A1 BAZ1A RNF216 DIAPH3 PCDH1 FMNL1 KNL1	1.63e-06	591	148	13	15231748
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	MAGEA1 FLNA COL12A1 ANK3 TRPM7 SPTAN1 UGGT1 ALG11 NEB ECE1 TTF1 LRRC8D INPP4B KCTD17 TGFB1 DLG4 WDR17 CAP1 MYBPC1	2.69e-06	1293	148	19	15342556
Pubmed	Mili interacts with tudor domain-containing protein 1 in regulating spermatogenesis.	TDRD1 AGO1 AGO3	4.16e-06	8	148	3	19345100
Pubmed	Importin 8 is a gene silencing factor that targets argonaute proteins to distinct mRNAs.	FLNA SPTAN1 EEF1A1 AGO1 AGO3 PTS	4.87e-06	101	148	6	19167051
Pubmed	METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis.	ACACA SPTAN1 UGGT1 LARP1B MAGED2 MTREX WDR17 SNRNP200	7.11e-06	231	148	8	36597993
Pubmed	Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.	MTA2 SPTAN1 POLR3A GTF2F2 IPO9 MAGED2 MTREX TAF1L SNRNP200 HELLS	7.24e-06	390	148	10	17643375
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MTA2 FLNA ANK3 IQGAP2 DOCK8 SPTAN1 RTN3 GSK3B NDUFV2 EEF1A1 AGO1 DLG4 PCDH1 ATP2B3 SNRNP200 METAP2 ATP2B4 CAP1 DNAH11	1.14e-05	1431	148	19	37142655
Pubmed	Role of collagen XII in skin homeostasis and repair.	COL12A1 TGFB1	1.80e-05	2	148	2	32890632
Pubmed	Plasma membrane Ca2+ ATPase isoform 4b binds to membrane-associated guanylate kinase (MAGUK) proteins via their PDZ (PSD-95/Dlg/ZO-1) domains.	DLG4 ATP2B4	1.80e-05	2	148	2	9430700
Pubmed	GSK3β attenuates TGF-β1 induced epithelial-mesenchymal transition and metabolic alterations in ARPE-19 cells.	GSK3B TGFB1	1.80e-05	2	148	2	28342867
Pubmed	Analysis of the tissue-specific distribution of mRNAs encoding the plasma membrane calcium-pumping ATPases and characterization of an alternately spliced form of PMCA4 at the cDNA and genomic levels.	ATP2B3 ATP2B4	1.80e-05	2	148	2	1531651
Pubmed	Modulation of CP2 family transcriptional activity by CRTR-1 and sumoylation.	TFCP2 TFCP2L1	1.80e-05	2	148	2	20661472
Pubmed	PSD-95 mediates membrane clustering of the human plasma membrane Ca2+ pump isoform 4b.	DLG4 ATP2B4	1.80e-05	2	148	2	19073225
Pubmed	Nucleosome Assembly Protein 1-Like 3 Enhances Cisplatin Resistance of Ovarian Cancer Cell by Activating Transforming Growth Factor-Beta Pathway.	NAP1L3 TGFB1	1.80e-05	2	148	2	32701410
Pubmed	Inhibiting glycogen synthase kinase-3 and transforming growth factor-β signaling to promote epithelial transition of human adipose mesenchymal stem cells.	GSK3B TGFB1	1.80e-05	2	148	2	28698144
Pubmed	FMNL1 down-regulation suppresses bone metastasis through reducing TGF-β1 expression in non-small cell lung cancer (NSCLC).	TGFB1 FMNL1	1.80e-05	2	148	2	31387165
Pubmed	CRTR-1, a developmentally regulated transcriptional repressor related to the CP2 family of transcription factors.	TFCP2 TFCP2L1	1.80e-05	2	148	2	11073954
Pubmed	Enhanced susceptibility of Ago1/3 double-null mice to influenza A virus infection.	AGO1 AGO3	1.80e-05	2	148	2	22318144
Pubmed	Collagen XII Regulates Corneal Stromal Structure by Modulating Transforming Growth Factor-β Activity.	COL12A1 TGFB1	1.80e-05	2	148	2	34774848
Pubmed	FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.	TGFB1 FUT8	1.80e-05	2	148	2	28982386
Pubmed	Nonsense Variant PRDM16-Q187X Causes Impaired Myocardial Development and TGF-β Signaling Resulting in Noncompaction Cardiomyopathy in Humans and Mice.	TGFB1 PRDM16	1.80e-05	2	148	2	38113297
Pubmed	Network organization of the human autophagy system.	MTA2 FLNA ACACA IQGAP2 TFCP2 GSK3B ADSS2 MAGED2 CSNK1G3 PI4KB	1.93e-05	437	148	10	20562859
Pubmed	Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development.	TRPM7 RYR2 ATP2B3 ATP2B4	2.08e-05	38	148	4	30786075
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	FLNA SPTAN1 UGGT1 LARP1B EEF1A1 AGO1 AGO3 MTREX	2.44e-05	274	148	8	34244482
Pubmed	The CRL4DCAF6 E3 ligase ubiquitinates CtBP1/2 to induce apoptotic signalling and promote intervertebral disc degeneration.	MTA2 MAGEA1 FLNA DOCK8 GSK3B IPO9 DLG4	2.44e-05	199	148	7	36688959
Pubmed	Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2.	FLNA NEB EHHADH MYBPC1	2.82e-05	41	148	4	18157088
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ANK3 TRPM7 SPTAN1 PEG3 ASH1L NAP1L3 CMYA5 KRIT1 EEF1A1 PTPRD RNF216 DLG4 FUT8 WDR17 GEN1 SNRNP200 METAP2	3.57e-05	1285	148	17	35914814
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	RTN3 TFCP2 GSK3B STAT2 GTF2F2 CTPS2 AGO3 MAGED2 PI4KB ARHGAP12 RNF216 DIAPH3 AP4B1 MTREX METAP2	3.93e-05	1038	148	15	26673895
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	MTA2 FLNA ACACA ATR SPTAN1 EEF1A1 EEF1A1P5 RPS26P11 MAGED2 SNRNP200	4.05e-05	477	148	10	31300519
Pubmed	No replication of genetic association between candidate polymorphisms and Alzheimer's disease.	ECE1 TFCP2 TGFB1	4.06e-05	16	148	3	19889475
Pubmed	A dual-strategy expression screen for candidate connectivity labels in the developing thalamus.	FAT3 PLXNC1 MDGA1 PCDH1 CDH6	4.52e-05	91	148	5	28558017
Pubmed	Turning catalytically inactive human Argonaute proteins into active slicer enzymes.	AGO1 AGO3	5.38e-05	3	148	2	23665583
Pubmed	Hydrostatic pressure promotes migration and filamin-A activation in fibroblasts with increased p38 phosphorylation and TGF-β production.	FLNA TGFB1	5.38e-05	3	148	2	34174537
Pubmed	Glycogen synthase kinase-3beta negatively regulates TGF-beta1 and Angiotensin II-mediated cellular activity through interaction with Smad3.	GSK3B TGFB1	5.38e-05	3	148	2	20599907
Pubmed	GSK3 and β-catenin determines functional expression of sodium channels at the axon initial segment.	ANK3 GSK3B	5.38e-05	3	148	2	22763697
Pubmed	CMYA5 establishes cardiac dyad architecture and positioning.	CMYA5 RYR2	5.38e-05	3	148	2	35449169
Pubmed	The C10orf76-PI4KB axis orchestrates CERT-mediated ceramide trafficking to the distal Golgi.	PI4KB ARMH3	5.38e-05	3	148	2	37195633
Pubmed	TGFβ overrides HNF4α tumor suppressing activity through GSK3β inactivation: implication for hepatocellular carcinoma gene therapy.	GSK3B TGFB1	5.38e-05	3	148	2	22960426
Pubmed	Chromatin remodelers HELLS, WDHD1 and BAZ1A are dynamically expressed during mouse spermatogenesis.	BAZ1A HELLS	5.38e-05	3	148	2	36194437
Pubmed	The roles of individual mammalian argonautes in RNA interference in vivo.	AGO1 AGO3	5.38e-05	3	148	2	24992693
Pubmed	Correlation of Aqueous Humor Lysyl Oxidase Activity with TGF-ß Levels and LOXL1 Genotype in Pseudoexfoliation.	TGFB1 LOXL1	5.38e-05	3	148	2	27116380
Pubmed	MiR-149 attenuates the proliferation and migration of TGF-β1-induced airway smooth muscle cells by targeting TRPM7 and affecting downstream MAPK signal pathway.	TRPM7 TGFB1	5.38e-05	3	148	2	33284571
Pubmed	circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer.	ACACA STAT2	5.38e-05	3	148	2	36328987
Pubmed	Requirement for active glycogen synthase kinase-3β in TGF-β1 upregulation of connective tissue growth factor (CCN2/CTGF) levels in human gingival fibroblasts.	GSK3B TGFB1	5.38e-05	3	148	2	23824844
Pubmed	NO2 inhalation induces maturation of pulmonary CD11c+ cells that promote antigenspecific CD4+ T cell polarization.	ITGAX TNFSF4	5.38e-05	3	148	2	20659336
Pubmed	Intracellular domains of amyloid precursor-like protein 2 interact with CP2 transcription factor in the nucleus and induce glycogen synthase kinase-3beta expression.	TFCP2 GSK3B	5.38e-05	3	148	2	16645641
Pubmed	A conserved PUF-Ago-eEF1A complex attenuates translation elongation.	EEF1A1 AGO1	5.38e-05	3	148	2	22231398
Pubmed	Argonaute2 is the catalytic engine of mammalian RNAi.	AGO1 AGO3	5.38e-05	3	148	2	15284456
Pubmed	Homologs of Drosophila Fushi-Tarazu factor 1 map to mouse chromosome 2 and human chromosome 9q33.	SPTAN1 NEB	5.38e-05	3	148	2	7789992
Pubmed	Protocadherin-1 binds to SMAD3 and suppresses TGF-β1-induced gene transcription.	TGFB1 PCDH1	5.38e-05	3	148	2	26209277
Pubmed	Novel regulation of vascular endothelial growth factor-A (VEGF-A) by transforming growth factor (beta)1: requirement for Smads, (beta)-CATENIN, AND GSK3(beta).	GSK3B TGFB1	5.38e-05	3	148	2	18952601
Pubmed	TRPM7 restrains plasmin activity and promotes transforming growth factor-β1 signaling in primary human lung fibroblasts.	TRPM7 TGFB1	5.38e-05	3	148	2	35864199
Pubmed	TFCP2/TFCP2L1/UBP1 transcription factors in cancer.	TFCP2 TFCP2L1	5.38e-05	3	148	2	29410248
Pubmed	Human DNA helicase HELQ participates in DNA interstrand crosslink tolerance with ATR and RAD51 paralogs.	ATR HELQ	5.38e-05	3	148	2	24005565
Pubmed	Argonaute proteins in cardiac tissue contribute to the heart injury during viral myocarditis.	AGO1 AGO3	5.38e-05	3	148	2	26764146
Pubmed	Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-Mediated DNA Damage Response.	ATR GSK3B	5.38e-05	3	148	2	31533931
Pubmed	Mechanistic differences in actin bundling activity of two mammalian formins, FRL1 and mDia2.	DIAPH3 FMNL1	5.38e-05	3	148	2	16556604
Pubmed	The filamentous actin cross-linking/bundling activity of mammalian formins.	DIAPH3 FMNL1	5.38e-05	3	148	2	18835565
Pubmed	Pw1, a novel zinc finger gene implicated in the myogenic and neuronal lineages.	PEG3 TGFB1	5.38e-05	3	148	2	8806818
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	FLNA FAT3 NEB FAM186A MTREX PRDM16 SNRNP200	6.82e-05	234	148	7	36243803
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	FLNA ANK3 CMYA5 NEB EEF1A1 EEF1A1P5 RPS26P11 AGO1 MAGED2 BRDT SNRNP200 CAP1 CPNE7	6.97e-05	844	148	13	25963833
Pubmed	Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons.	ATP2B3 ATP2B4	1.07e-04	4	148	2	12209837
Pubmed	Molecular dissection of human Argonaute proteins by DNA shuffling.	AGO1 AGO3	1.07e-04	4	148	2	23748378
Pubmed	Expression and role of calcium-ATPase pump and sodium-calcium exchanger in differentiated trophoblasts from human term placenta.	ATP2B3 ATP2B4	1.07e-04	4	148	2	12784250
Pubmed	Akt2 mediates TGF-β1-induced epithelial to mesenchymal transition by deactivating GSK3β/snail signaling pathway in renal tubular epithelial cells.	GSK3B TGFB1	1.07e-04	4	148	2	25059120
Pubmed	The plasma membrane calcium pump in health and disease.	ATP2B3 ATP2B4	1.07e-04	4	148	2	23413890
Pubmed	Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes.	ATP2B3 ATP2B4	1.07e-04	4	148	2	8245032
Pubmed	MicroRNA-124 suppresses growth and aggressiveness of osteosarcoma and inhibits TGF-β-mediated AKT/GSK-3β/SNAIL-1 signaling.	GSK3B TGFB1	1.07e-04	4	148	2	29488603
Pubmed	Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes.	ATP2B3 ATP2B4	1.07e-04	4	148	2	7989379
Pubmed	Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps.	ATP2B3 ATP2B4	1.07e-04	4	148	2	11152753
Pubmed	Slicing-independent RISC activation requires the argonaute PAZ domain.	AGO1 AGO3	1.07e-04	4	148	2	22795694
Pubmed	PMCA1 depletion in mouse eggs amplifies calcium signaling and impacts offspring growth†.	ATP2B3 ATP2B4	1.07e-04	4	148	2	36130203
Pubmed	Developmental expression of the four plasma membrane calcium ATPase (Pmca) genes in the mouse.	ATP2B3 ATP2B4	1.07e-04	4	148	2	10434059
Pubmed	Importance of translation and nonnucleolytic ago proteins for on-target RNA interference.	AGO1 AGO3	1.07e-04	4	148	2	18771919
Pubmed	Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs.	AGO1 AGO3	1.07e-04	4	148	2	15260970
Pubmed	Calcium pumps of plasma membrane and cell interior.	ATP2B3 ATP2B4	1.07e-04	4	148	2	15101689
Pubmed	Plasma membrane calcium ATPases as critical regulators of calcium homeostasis during neuronal cell function.	ATP2B3 ATP2B4	1.07e-04	4	148	2	10577388
Pubmed	Structural organization, ion transport, and energy transduction of P-type ATPases.	ATP2B3 ATP2B4	1.07e-04	4	148	2	8634322
Pubmed	The TGF-β-induced up-regulation of NKG2DLs requires AKT/GSK-3β-mediated stabilization of SP1.	GSK3B TGFB1	1.07e-04	4	148	2	28165192
Pubmed	Transforming growth factor-{beta}-inducible phosphorylation of Smad3.	GSK3B TGFB1	1.07e-04	4	148	2	19218245
Pubmed	ATP-dependent human RISC assembly pathways.	AGO1 AGO3	1.07e-04	4	148	2	19966796
Pubmed	Nebulin regulates thin filament length, contractility, and Z-disk structure in vivo.	FLNA NEB	1.07e-04	4	148	2	16902413
Pubmed	A Requirement for Argonaute 4 in Mammalian Antiviral Defense.	AGO1 AGO3	1.07e-04	4	148	2	32049003
Pubmed	Slitrk4 is required for the development of inhibitory neurons in the fear memory circuit of the lateral amygdala.	SLITRK3 PTPRD DLG4	1.10e-04	22	148	3	38736483
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	MAGEA1 FLNA COL12A1 ACACA SPTAN1 UGGT1 RTN3 ECE1 GSK3B TGFB1 ERGIC1 BAZ1A DIAPH3 METAP2 NENF HELLS	1.38e-04	1297	148	16	33545068
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	FLNA ANK3 SPTAN1 EPS8L1 POF1B STAT2 EEF1A1 DIAPH3 PCDH1 ATP2B4	1.63e-04	565	148	10	25468996
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	ANK3 EPS8L1 TEX11 ECE1 GHR SCAF1 BAZ1A FMNL1	1.67e-04	361	148	8	26167880
Pubmed	Differential expression of Dicer and Argonaute genes during the differentiation of human neuroblastoma cells.	AGO1 AGO3	1.78e-04	5	148	2	19393748
Pubmed	Quantitative functions of Argonaute proteins in mammalian development.	AGO1 AGO3	1.78e-04	5	148	2	22474261
Pubmed	The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis.	AGO1 AGO3	1.78e-04	5	148	2	12414724
Pubmed	Differential left-to-right atria gene expression ratio in human sinus rhythm and atrial fibrillation: Implications for arrhythmogenesis and thrombogenesis.	RYR2 TGFB1	1.78e-04	5	148	2	27494721
Pubmed	The C-terminal half of human Ago2 binds to multiple GW-rich regions of GW182 and requires GW182 to mediate silencing.	AGO1 AGO3	1.78e-04	5	148	2	19324964
Pubmed	Short-interfering-RNA-mediated gene silencing in mammalian cells requires Dicer and eIF2C translation initiation factors.	AGO1 AGO3	1.78e-04	5	148	2	12526743
Pubmed	Prdm3 and Prdm16 are H3K9me1 methyltransferases required for mammalian heterochromatin integrity.	ASH1L PRDM16	1.78e-04	5	148	2	22939622
Pubmed	Differential expression of components of the microRNA machinery during mouse organogenesis.	AGO1 AGO3	1.78e-04	5	148	2	16036130
GeneFamily	X-linked mental retardation\|RNA helicases	HELQ HFM1 MTREX SNRNP200	2.02e-07	11	92	4	1168
GeneFamily	Fibronectin type III domain containing	COL12A1 CMYA5 GHR PTPRD PTPRQ MYBPC1	1.66e-04	160	92	6	555
GeneFamily	Argonaute/PIWI family	AGO1 AGO3	7.03e-04	8	92	2	408
GeneFamily	ATPases Ca2+ transporting	ATP2B3 ATP2B4	9.01e-04	9	92	2	1209
GeneFamily	MAGE family	MAGEA1 MAGEB2 MAGED2	1.10e-03	40	92	3	1136
GeneFamily	Dyneins, axonemal	DNAH3 DNAH11	3.31e-03	17	92	2	536
GeneFamily	Zinc fingers C2H2-type\|PR/SET domain family	PRDM10 PRDM16	3.31e-03	17	92	2	1197
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000	NAAA ATR TRPM7 PEG3 ASH1L CFAP210 LARP1B TEX11 NEB ECE1 GSK3B RYR2 PCNX2 SOHLH2 AGO3 BRDT PLXNC1 KCTD14 PRDM16 HELLS	3.94e-07	778	146	20	gudmap_developingGonad_e18.5_ovary_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000	FLNA COL12A1 NAAA FAT3 PEG3 CFAP210 TFCP2 RYR2 GHR MAGED2 PLXNC1 LOXL1 KCTD14 DLG4 ATP2B3 CDH6 ATP2B4 NENF MYBPC1	2.41e-06	797	146	19	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000	FLNA COL12A1 NAAA FAT3 PEG3 RYR2 GHR ACSM3 CTPS2 PTPRD MAGED2 PLXNC1 LOXL1 KCTD14 ATP2B3 CDH6 ATP2B4 NENF	3.43e-06	740	146	18	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000	NAAA ATR TRPM7 PEG3 ASH1L CFAP210 LARP1B TEX11 ECE1 GSK3B RYR2 PCNX2 SOHLH2 AGO3 BRDT PLXNC1 KCTD14 HELLS	9.18e-06	795	146	18	gudmap_developingGonad_e16.5_ovary_1000
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_1000	ATR LARP1B TEX11 SOHLH2 BRDT VPS13A HFM1	1.48e-05	115	146	7	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_1000
CoexpressionAtlas	dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_500	ATR TEX11 SOHLH2 BRDT HFM1	4.13e-05	56	146	5	gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_500
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000	FLNA NAAA ACACA FAT3 PEG3 GHR PTPRD PLXNC1 CSNK1G2 LOXL1 KCTD14 DIAPH3 HSD17B3 ATP2B3 CDH6 ATP2B4 MYBPC1	5.58e-05	827	146	17	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500	ATR PEG3 ASH1L LARP1B TEX11 GSK3B RYR2 SOHLH2 BRDT KCTD14 HELLS	6.93e-05	382	146	11	gudmap_developingGonad_e14.5_ ovary_500
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000	NAAA PEG3 ASH1L LARP1B TEX11 NEB ECE1 GSK3B RYR2 PCNX2 SOHLH2 AGO3 MAGED2 BRDT PLXNC1 KCTD14	8.24e-05	770	146	16	gudmap_developingGonad_P2_ovary_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	FLNA IQGAP2 FAT3 PEG3 SPIN4 GHR PTPRD PLXNC1 LOXL1 DLG4 DIAPH3 HSD17B3 GEN1 CDH6 ATP2B4 KNL1	9.16e-05	777	146	16	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_200	PEG3 ASH1L TEX11 GSK3B RYR2 PLXNC1 KCTD14	1.00e-04	155	146	7	gudmap_developingGonad_e16.5_ovary_200
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_500	ATR TEX11 SOHLH2 BRDT HFM1	1.06e-04	68	146	5	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_500
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_200	COL12A1 NAAA PEG3 RYR2 PLXNC1 KCTD14 CDH6	1.13e-04	158	146	7	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_200
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_500	ATR TEX11 SOHLH2 BRDT HFM1	1.13e-04	69	146	5	gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_500
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000	ATR TEX11 SOHLH2 BRDT RNF216 HFM1	1.13e-04	110	146	6	gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	FLNA NAAA FAT3 PEG3 SPIN4 GHR PTPRD PLXNC1 KCTD14 DIAPH3 HSD17B3 GEN1 CDH6 ATP2B4 NENF KNL1	1.16e-04	793	146	16	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#4_top-relative-expression-ranked_1000	ATR TEX11 SOHLH2 BRDT HFM1	1.39e-04	72	146	5	gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k4_1000
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#4_top-relative-expression-ranked_1000	NAAA LARP1B TEX11 RYR2 PCNX2 SOHLH2 KCTD14	1.65e-04	168	146	7	gudmap_developingGonad_P2_ovary_1000_k4
CoexpressionAtlas	DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_100	ECE1 BRDT PLXNC1 KCTD14 HSD17B3	2.15e-04	79	146	5	gudmap_developingGonad_e16.5_testes_100
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500	FLNA IQGAP2 FAT3 PEG3 GHR PLXNC1 KCTD14 DIAPH3 HSD17B3 ATP2B4	2.18e-04	364	146	10	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_200	GSK3B SOHLH2 KCTD14 HELLS	2.57e-04	45	146	4	gudmap_developingGonad_e14.5_ ovary_200_k1
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_500	ATR LARP1B PHKA1 SOHLH2 VPS13A HFM1	2.71e-04	129	146	6	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k4_500
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000	NAAA ATR PEG3 ASH1L LARP1B TEX11 ECE1 GSK3B RYR2 SOHLH2 AGO3 BRDT VPS13A KCTD14 HELLS	3.02e-04	776	146	15	gudmap_developingGonad_e14.5_ ovary_1000
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_100	COL12A1 NAAA PEG3 RYR2 KCTD14	3.19e-04	86	146	5	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_100
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_500	PEG3 TEX11 RYR2 SOHLH2 KCTD14 PRDM16	3.32e-04	134	146	6	gudmap_developingGonad_e18.5_ovary_500_k1
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000	FLNA COL12A1 NAAA ACACA FAT3 PEG3 RYR2 GHR PTPRD PLXNC1 KCTD14 DIAPH3 ATP2B3 CDH6 NENF	3.32e-04	783	146	15	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500	PEG3 ASH1L TEX11 NEB GSK3B RYR2 SOHLH2 PLXNC1 KCTD14 PRDM16	3.54e-04	387	146	10	gudmap_developingGonad_e18.5_ovary_500
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500	ATR PEG3 ASH1L TEX11 GSK3B RYR2 SOHLH2 PLXNC1 KCTD14 HELLS	3.54e-04	387	146	10	gudmap_developingGonad_e16.5_ovary_500
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	NAAA IQGAP2 TRPM7 FAT3 TDRD1 TTF1 NUDT12 AGO1 BAZ1A VPS13A DLG4 MDGA1 PRDM16 GEN1 CDH6 KNL1 CXCR2 HELLS	3.62e-04	1060	146	18	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_200	FAT3 PEG3 PLXNC1 KCTD14 HSD17B3 ATP2B4	3.89e-04	138	146	6	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000	ZHX3 IQGAP2 TRPM7 PEG3 ASH1L ALG11 GSK3B RYR2 GHR METAP2	4.33e-04	397	146	10	gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5
CoexpressionAtlas	dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000	ZHX3 COL12A1 NAAA NT5C3A PEG3 ECE1 RYR2 ACSM3 CTPS2 MAGED2 PLXNC1 ARHGAP12 KCTD14 ATP2B3 NENF	4.39e-04	804	146	15	gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	CERKL TRPM7 FAT3 SPTAN1 PEG3 RTN3 ALG11 LRRC8D NUDT12 AGO1 BAZ1A RALGPS1 ARHGAP12 VPS13A FUT8 MDGA1 PRDM16 GEN1 CDH6 KNL1 HELLS	4.52e-04	1370	146	21	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_200	COL12A1 PEG3 RYR2 PLXNC1 KCTD14 CDH6	4.70e-04	143	146	6	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_200
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_200	ATR TEX11 SOHLH2 BRDT HFM1 HELLS	4.70e-04	143	146	6	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000	IQGAP2 TRPM7 FAT3 ASH1L ALG11 GSK3B RYR2 GHR METAP2	4.76e-04	330	146	9	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000
CoexpressionAtlas	dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_1000	COL12A1 NAAA PEG3 RYR2 CTPS2 KCTD14 ATP2B3 MYBPC1	5.19e-04	266	146	8	gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k4_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500	ZHX3 ANK3 IQGAP2 ABHD2 FAT3 POF1B GHR HOXD13 KCTD14 METAP2	5.35e-04	408	146	10	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000	ACACA ATR LARP1B TEX11 TDRD1 PHKA1 SOHLH2 BRDT BAZ1A VPS13A RNF216 HFM1 DIAPH3 FUT8 HELLS	5.38e-04	820	146	15	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_200	PEG3 TEX11 GSK3B SOHLH2 KCTD14 HELLS	5.64e-04	148	146	6	gudmap_developingGonad_e14.5_ ovary_200
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_200	IQGAP2 PLXNC1 HSD17B3	5.80e-04	24	146	3	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_200
CoexpressionAtlas	dev gonad_e13.5_M_SertoliCell_Sox9_k-means-cluster#2_top-relative-expression-ranked_1000	NAAA NT5C3A ACSM3 PTPRD KCTD14 ATP2B3 NENF	6.19e-04	209	146	7	gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_k2_1000
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_200	COL12A1 NAAA PEG3 RYR2 PLXNC1 KCTD14	6.49e-04	152	146	6	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_200
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200	FAT3 PEG3 PLXNC1 KCTD14 HSD17B3 ATP2B4	6.72e-04	153	146	6	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_200
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500	NAAA IQGAP2 TRPM7 FAT3 TDRD1 TTF1 POF1B NUDT12 ACSM3 AGO1 BAZ1A PLCH2 VPS13A DLG4 MDGA1 PRDM16 GEN1 CDH6 KNL1 CXCR2 HELLS	6.83e-04	1414	146	21	facebase_RNAseq_e10.5_Emin_MedNas_2500
CoexpressionAtlas	Stem Cells, SC.LTSL.BM, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-2	IQGAP2 PLXNC1 DIAPH3 FUT8 MDGA1 PRDM16 ATP2B4 KNL1 CXCR2 HELLS	6.94e-04	422	146	10	GSM399442_500
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_200	PEG3 ASH1L GSK3B PLXNC1 KCTD14 HELLS	8.21e-04	159	146	6	gudmap_developingGonad_e12.5_epididymis_200
CoexpressionAtlas	dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_500	COL12A1 NAAA ACACA PEG3 RYR2 ACSM3 PLXNC1 KCTD14 HSD17B3 ATP2B3	8.30e-04	432	146	10	gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_500
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 FAT3 TEX11 NEB RYR2 PTPRD PTPRQ DNAH11	2.05e-07	184	149	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 FAT3 TEX11 NEB RYR2 PTPRD PTPRQ DNAH11	2.05e-07	184	149	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 FAT3 TEX11 NEB RYR2 PTPRD PTPRQ DNAH11	2.05e-07	184	149	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	ANK3 ABHD2 CMYA5 INPP4B RYR2 RNF216 PRDM16 ATP2B4	2.94e-07	193	149	8	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SPTAN1 PEG3 GCNT4 INPP4B SOHLH2 FCRL3 SLC16A10	8.58e-07	153	149	7	7480522a47e367f8facc4f5d599fbaf0b5ad4007
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SPTAN1 PEG3 GCNT4 INPP4B SOHLH2 FCRL3 SLC16A10	9.77e-07	156	149	7	53ded973358e3e48054130131e959f0d1f4ef60f
ToppCell	facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-B_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACAP1 DOCK8 HELQ ITGAX TGFB1 PRDM10 OCSTAMP	1.95e-06	173	149	7	a693772987f1baee533dd0bd285a3c7b5619a73b
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	ACAP1 ANK3 SPTAN1 ASH1L INPP4B VPS13A FUT8	2.63e-06	181	149	7	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	ANK3 ABHD2 CMYA5 INPP4B RYR2 RNF216 ATP2B4	2.73e-06	182	149	7	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ARHGEF28 FAT3 RYR2 PTPRD AK5 VPS13A ATP2B4	3.15e-06	186	149	7	84ba666237c18189d7e7556bd92dd953af733c00
ToppCell	COVID-19-lung-CD4+_Treg\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ACAP1 ANK3 IQGAP2 DOCK8 INPP4B PCNX2 FUT8	3.75e-06	191	149	7	5a4ad5ae5c2dbfb225158cb598ef649c26a48350
ToppCell	COVID-19-lung-CD4+_T_cells_metabolically_active\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ACAP1 IQGAP2 DOCK8 INPP4B PCNX2 FUT8 FMNL1	4.02e-06	193	149	7	326fd2ce2c4b51e5a38f2a7a09f22f8f0e92735a
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MXRA5 ANK3 IQGAP2 RTN3 CMYA5 PRDM16 METAP2	4.16e-06	194	149	7	04bfc555743f7d8821439d05ae442d15e9886c59
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGEF28 ANK3 ACSF2 CMYA5 TFCP2L1 PTPRD CDH6	4.16e-06	194	149	7	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MXRA5 ANK3 IQGAP2 RTN3 CMYA5 PRDM16 METAP2	4.16e-06	194	149	7	69bff17df4a760ccf081cf52ff04af02c14f448d
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ACAP1 ABI3 IQGAP2 FCRL3 AK5 FMNL1 CXCR2	4.30e-06	195	149	7	e1b7ef4ba2ab14d3c839b6305d91efcfd0826220
ToppCell	3'-Distal_airway-Immune_Lymphocytic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ACAP1 ABI3 IQGAP2 FCRL3 AK5 FMNL1 CXCR2	4.30e-06	195	149	7	4a60b51f92830882872f2fe1a911db2970faf071
ToppCell	10x5'v1-week_12-13-Hematopoietic-MK-early_MK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	NT5C3A CFAP210 INPP4B TGFB1 MAGED2 FUT8 SLC16A10	4.30e-06	195	149	7	fa5fc6f605deb5cae96eec14ba4000b19f877ba6
ToppCell	10x5'-Liver-Lymphocytic_NK-NK_CD16\|Liver / Manually curated celltypes from each tissue	FLNA ABI3 TGFB1 FCRL3 AK5 PCDH1 CXCR2	4.45e-06	196	149	7	e6d4853ccefbcd45a019cee595811f0474dcc036
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_NK-NK_CD16\|lymph-node_spleen / Manually curated celltypes from each tissue	FLNA ABI3 IQGAP2 ITGAX TGFB1 PCDH1 CXCR2	4.45e-06	196	149	7	f7e5a7fad4547e8ab9ab8b140239281832fb4260
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CERKL ACAP1 IQGAP2 NT5C3A FUT8 ATP2B4 CPNE7	4.60e-06	197	149	7	1ca06d6d288cb58a6e8062ebc01831e58ee5be4b
ToppCell	LPS_only-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-iNKT-MAIT\|LPS_only / Treatment groups by lineage, cell group, cell type	ACAP1 DOCK8 ITGAX TGFB1 FCRL3 FMNL1 HELLS	4.92e-06	199	149	7	b62a756b5472972156d05051a58671a58bef1f16
ToppCell	LPS_IL1RA-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-iNKT-MAIT\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ACAP1 IQGAP2 DOCK8 ITGAX TGFB1 FCRL3 FMNL1	4.92e-06	199	149	7	0c743e4e88cbd2ca72e5161ca22a3e974b26f9b4
ToppCell	COVID-19-lung\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLNA DOCK8 ITGAX STAT2 BAZ1A PLXNC1 FMNL1	4.92e-06	199	149	7	155b03b859157013e9142e9248551369127d9204
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CERKL DNAH3 CFAP300 EPS8L1 CFAP210 POF1B ADGB	5.08e-06	200	149	7	da12821e8a0657869ca0f75d351cce2d7605a505
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell\|6m / Sample Type, Dataset, Time_group, and Cell type.	CERKL ABHD2 CFAP210 ADGB ATP2B3 DNAH11 SLC16A10	5.08e-06	200	149	7	177f9ad8dd8635394c575a2b30140184df0bd51e
ToppCell	LPS_IL1RA_TNF-Epithelial_airway\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CERKL DNAH3 CFAP300 EPS8L1 CFAP210 POF1B ADGB	5.08e-06	200	149	7	72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb
ToppCell	PBMC-Severe-cDC_1\|Severe / Compartment, Disease Groups and Clusters	CERKL FLNA TFCP2L1 PLXNC1 WDR17	7.79e-06	81	149	5	6d1e524f000b71c935359afc801a1d31f218fec8
ToppCell	LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH3 CFAP300 CFAP210 GCNT4 ADGB DNAH11	1.07e-05	148	149	6	d61123f0c811287843d066b932b4a9ff09c07c5b
ToppCell	LPS-antiTNF-Epithelial_airway-Ciliated_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH3 CFAP300 CFAP210 GCNT4 ADGB DNAH11	1.07e-05	148	149	6	c8e93b87212f55774223caa385859c566fa1981f
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	GCNT4 INPP4B EEF1A1 EEF1A1P5 ADGB SLC16A10	1.15e-05	150	149	6	c922dbb4c9c12ccf08bd5f6168b20606c605d052
ToppCell	facs-MAT-Fat-3m-Epithelial-nan\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT3 HFM1 ADAM2 MYBPC1 DNAH11	1.53e-05	93	149	5	dbfaa7f23d25f5c286ab7ca3ca795b734cb95153
ToppCell	facs-MAT-Fat-3m-Epithelial-epithelial_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT3 HFM1 ADAM2 MYBPC1 DNAH11	1.53e-05	93	149	5	0d6d1d8dd9c91ba31eb35a4b5979d087890936c1
ToppCell	facs-MAT-Fat-3m-Epithelial\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT3 HFM1 ADAM2 MYBPC1 DNAH11	1.53e-05	93	149	5	abffb1fd5a919b7c08e62e1c3c08a8dd8783a4ca
ToppCell	Control-B_intermediate-10\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	CFAP300 ANK3 NEB ITGAX FCRL3 PLXNC1	1.78e-05	162	149	6	aa80452b972bb8ad3670ffaba4ce26fadb33b185
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NAAA ITGAX BAZ1A FMNL1 CXCR2 SLC16A10	1.98e-05	165	149	6	1dcd6b8aa192baeaa1f7bb334843edab6049b96f
ToppCell	droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAAA ANK3 ABHD2 DLG4 DIAPH3 MDGA1	1.98e-05	165	149	6	354978d4f35154d7b2e36e94de669e045adef512
ToppCell	normal_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th\|normal_Lung / Location, Cell class and cell subclass	ACAP1 GCNT4 PTS RALGPS1 FMNL1 CPNE7	2.05e-05	166	149	6	ff32422390852546e0cb216192452e9c47bd9509
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FAT3 CMYA5 NEB AK5 PTPRQ MYBPC1	2.12e-05	167	149	6	d78356bf0c473816dbabaee51984940bd822f84e
ToppCell	droplet-Liver-Npc-18m-Myeloid-myeloid_leukocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAAA ITGAX KCTD14 GEN1 FMNL1 CXCR2	2.19e-05	168	149	6	ce5e92a1df3acfa5cd8d5a134e4af231dc592a13
ToppCell	droplet-Liver-Npc-18m-Myeloid-macrophage/monocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAAA ITGAX KCTD14 GEN1 FMNL1 CXCR2	2.19e-05	168	149	6	22c89d4eb44573f6301069ec7ca7cbd0dd958403
ToppCell	PND14-Immune-Immune_Myeloid-DC-cDC2\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NAAA IQGAP2 ITGAX BAZ1A FMNL1 KNL1	2.34e-05	170	149	6	9e94fa0d05abed3438b28296a293767096d517d6
ToppCell	10x5'-GI_small-bowel-Lymphocytic_NK-NK_CD16\|GI_small-bowel / Manually curated celltypes from each tissue	FLNA ITGAX FCRL3 AK5 FRMPD3 CXCR2	2.42e-05	171	149	6	1ee505b91f15191d294a5d491ecdf154c08b8622
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FAT3 INPP4B RYR2 GHR PRDM16 CDH6	2.58e-05	173	149	6	cb6389536195443633adb06e5f1b7483530773d1
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_NKT\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ACAP1 IQGAP2 DOCK8 INPP4B TGFB1 PCNX2	2.94e-05	177	149	6	f1efd9c3074d5635700fe7fbebf3dd0b1e0a84f1
ToppCell	Ciliated_cells-B-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	CERKL DNAH3 EPS8L1 CFAP210 ADGB DNAH11	2.94e-05	177	149	6	c38138fb5ad9766c2d240811210c854338cd612e
ToppCell	Severe-B_intermediate-10\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ANK3 NEB ITGAX OR52K1 FCRL3 PLXNC1	3.03e-05	178	149	6	b7374a97c51239782bed658381a02cb1b3d9bf66
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZHX3 ACACA TTF1 STAT2 POLR3A PLXNC1	3.03e-05	178	149	6	c87945146b2734141f07b39d268e0d8086ee0364
ToppCell	LPS_only-Lymphocytic_NKT-iNKT/MAIT\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ACAP1 IQGAP2 DOCK8 ITGAX TGFB1 FCRL3	3.13e-05	179	149	6	de3ddc1264e43727be50d69b81cc84a3c91812a2
ToppCell	facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAAA IQGAP2 DOCK8 ITGAX KCTD14 FMNL1	3.13e-05	179	149	6	33ed9270d257895ff3b40df2c1af878119c9f492
ToppCell	LPS_only-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ACAP1 IQGAP2 DOCK8 ITGAX TGFB1 FCRL3	3.13e-05	179	149	6	def981e97e3ff9019910c9af3861ca0d08eb0d0f
ToppCell	Adult-Immune-T_lymphocyte-D122\|Adult / Lineage, Cell type, age group and donor	ACAP1 IQGAP2 DOCK8 INPP4B PCNX2 CPNE7	3.22e-05	180	149	6	06c371d0f0c5a7b234dd143e98800e19af95a8b5
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ANK3 IQGAP2 SPTAN1 NAP1L3 INPP4B ATP2B4	3.22e-05	180	149	6	d9dae9db8e17f6990032ee6cfa8393fae4768ca5
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ACSF2 PTPRD SLC13A1 EHHADH PLCH2 CDH6	3.43e-05	182	149	6	e1e58176f533092b6b974ca1ce8b02192a6e193d
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	UGGT1 ITGAX BAZ1A DIAPH3 KNL1 SLC16A10	3.43e-05	182	149	6	21dcab170ffeef89faa9fee5008568cb6e15c694
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ACSF2 PTPRD SLC13A1 EHHADH PLCH2 CDH6	3.43e-05	182	149	6	4a9c13932e7163fd37a3dcc4c6ca3bbea5372459
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ACSF2 PTPRD SLC13A1 EHHADH PLCH2 CDH6	3.43e-05	182	149	6	57bb5a2da976464ba7c4460106bd9f692008ebd9
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	FLNA ARHGEF28 FAT3 INPP4B PRDM16 CDH6	3.54e-05	183	149	6	818fd886e0188091310825f9145fa53328f2c979
ToppCell	Mild/Remission-B_intermediate-10\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	FLNA ANK3 NEB ITGAX FCRL3 PLXNC1	3.54e-05	183	149	6	278064c9f0582463b83bf156d34e77f60187613b
ToppCell	Control-Epithelial_cells-Airway_goblet\|Control / group, cell type (main and fine annotations)	ARHGEF28 EPS8L1 POF1B INPP4B MGAM2 MYBPC1	3.65e-05	184	149	6	d92a71441e4e19f8c301999d8186f8e48e3cd162
ToppCell	P03\|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FLNA FAT3 EEF1A1 PTPRD LOXL1 NENF	3.76e-05	185	149	6	a07dbe1f76e40734a28826423a5cc64b8e56af5e
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CERKL DNAH3 CFAP300 CFAP210 ADGB DNAH11	3.87e-05	186	149	6	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-Undetermined\|Fibroblasts / Location, Cell class and cell subclass	ABI3 ACACA PTPRD PLXNC1 ARHGAP12 ARMH3	3.87e-05	186	149	6	403ac98f72a42721f84fbd7826f251a88ae534a2
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 ACSM3 PTPRD SLC13A1 FUT8 CDH6	3.87e-05	186	149	6	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ACSF2 PTPRD SLC13A1 EHHADH PLCH2 CDH6	3.99e-05	187	149	6	1b82920588f9e26ef1db244d452736d75fcfd342
ToppCell	COVID-19-kidney-tDL\|kidney / Disease (COVID-19 only), tissue and cell type	DOCK8 PTPRD SLC13A1 EHHADH VPS13A CDH6	3.99e-05	187	149	6	d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IQGAP2 GCNT4 INPP4B EEF1A1 EEF1A1P5 SLC13A1	3.99e-05	187	149	6	e61c1755531469dd3850c9740474b5ad4e0499c1
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ACSF2 PTPRD SLC13A1 EHHADH PLCH2 CDH6	3.99e-05	187	149	6	c1e4c0345f9bfa0538730bad5ff3fa5240168b25
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	ANK3 ABHD2 CMYA5 NEB INPP4B RYR2	4.11e-05	188	149	6	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	human_hepatoblastoma-NK.T_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	ACAP1 DOCK8 INPP4B FCRL3 PLCH2 FMNL1	4.11e-05	188	149	6	71b7599e7e1d63cc0c8518c0501533755951d58f
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	FLNA ARHGEF28 FAT3 INPP4B RYR2 PRDM16	4.11e-05	188	149	6	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ACAP1 ANK3 SPTAN1 GCNT4 INPP4B AK5	4.23e-05	189	149	6	9ab77c6fcb573854da5922412f53d2168bda6b58
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|RV / Chamber and Cluster_Paper	ANK3 TRPM7 CMYA5 INPP4B RYR2 PRDM16	4.23e-05	189	149	6	9c1debd65c13d63fd4f3158917d621b44b714c26
ToppCell	tumor_Lung-Fibroblasts-Pericytes\|Fibroblasts / Location, Cell class and cell subclass	EPS8L1 ECE1 INPP4B PCDH1 CDH6 DNAH11	4.23e-05	189	149	6	9c407b17d7945e81e1ae6c18452f5d20fb09d563
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CERKL DNAH3 CFAP300 CFAP210 ADGB DNAH11	4.23e-05	189	149	6	a3cd4c2da4feb9bdcd8957f3e344d095da1367b8
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CERKL DNAH3 CFAP300 CFAP210 ADGB DNAH11	4.23e-05	189	149	6	93b1026bb1ba759e5704561c9a5de14a30c08894
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK8 ACSM3 PTPRD SLC13A1 EHHADH CDH6	4.36e-05	190	149	6	989d4eefd22d66ecb857836f8fdbcf41e3047f84
ToppCell	cellseq2-Epithelial-Epithelial_Airway\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CERKL DNAH3 CFAP300 CFAP210 ADGB DNAH11	4.36e-05	190	149	6	17829f4de31b3d9e4d71ba4817d18842aa699773
ToppCell	IPF-Lymphoid-NK\|Lymphoid / Disease state, Lineage and Cell class	ABI3 IQGAP2 ABHD2 ITGAX FCRL3 CXCR2	4.49e-05	191	149	6	f2ddc0962007d7a4e78fbd916ebb62fc557d480a
ToppCell	COVID-19-lung-CD4+_Treg\|lung / Disease (COVID-19 only), tissue and cell type	ACAP1 ANK3 IQGAP2 DOCK8 INPP4B PCNX2	4.49e-05	191	149	6	73ea3078c1f55cd47e4d99e77b3ce4ff17549d49
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ACAP1 ANK3 GCNT4 INPP4B EEF1A1 AK5	4.62e-05	192	149	6	78546a6e077076834fd717607610ab6df3b6e7ba
ToppCell	Fetal_29-31_weeks-Immune-monocyte-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NAAA IQGAP2 DOCK8 ITGAX PLXNC1 FMNL1	4.62e-05	192	149	6	5417f024fcc89eaeab33f4a2c6421d1cfabd681b
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ABI3 IQGAP2 FCRL3 AK5 FMNL1 CXCR2	4.62e-05	192	149	6	1922b0350d3375e67c314dbce8074e5cf986f2ef
ToppCell	Control-B_intermediate-10\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ANK3 NEB ITGAX FCRL3 PLXNC1 GEN1	4.62e-05	192	149	6	224bd958369ba8fa0d7be2126f7dc61c9f6ac19d
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ABI3 IQGAP2 FCRL3 AK5 FMNL1 CXCR2	4.62e-05	192	149	6	97c197643e59835c6d45dde9e549c9a1b1bb7288
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ABI3 IQGAP2 FCRL3 AK5 FMNL1 CXCR2	4.62e-05	192	149	6	a4d161e3d48bc020e687808b352325ef9d1cc1f3
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CERKL DNAH3 CFAP300 CFAP210 ADGB DNAH11	4.76e-05	193	149	6	e1b76102f812c433195d1e8811fdd3293a7bc22e
ToppCell	mild_COVID-19-CD4+_T_naive\|mild_COVID-19 / disease group, cell group and cell class (v2)	ANK3 GCNT4 INPP4B EEF1A1 AK5 SLC16A10	4.76e-05	193	149	6	40fc4a519c883c6c269a9c05be36ae906f75426a
ToppCell	mild_COVID-19-CD4+_T_naive\|World / disease group, cell group and cell class (v2)	ANK3 GCNT4 INPP4B EEF1A1 AK5 SLC16A10	4.76e-05	193	149	6	42ddacc55658ea6ba4248ac19c9c3709f342b4f5
ToppCell	COVID-19-kidney-T-cells-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ACAP1 IQGAP2 DOCK8 INPP4B PCNX2 FCRL3	4.76e-05	193	149	6	5b84fa640cf30dea55fde53b810f850ff946d253
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ACAP1 ANK3 INPP4B EEF1A1 AK5 SLC16A10	4.90e-05	194	149	6	2e2019a7bf57f257f0ff9b24eacff59dbb952ebb
ToppCell	367C-Lymphocytic-NK_cells\|367C / Donor, Lineage, Cell class and subclass (all cells)	ACAP1 ABI3 FCRL3 AK5 PLCH2 CXCR2	4.90e-05	194	149	6	2e447de50b3f4b59e3b9928df83879955fed93cc
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ACAP1 ANK3 INPP4B EEF1A1 AK5 SLC16A10	4.90e-05	194	149	6	d788d5bd1e651706e7e2d54ada546a5e84f86ff0
ToppCell	NS-critical-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CERKL DNAH3 CFAP300 CFAP210 ADGB DNAH11	4.90e-05	194	149	6	1ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCell	Healthy_donor-CD4+_T_naive\|Healthy_donor / disease group, cell group and cell class (v2)	ANK3 GCNT4 INPP4B EEF1A1 AK5 SLC16A10	4.90e-05	194	149	6	a8a0368a4e0eb5654fdffc8a779b08ad402aa2eb
ToppCell	human_hepatoblastoma-NK.T_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	ACAP1 DOCK8 INPP4B FCRL3 PLCH2 FMNL1	4.90e-05	194	149	6	997b02a22d7c89a8fd5615bb79a2a8a34fc3fee6
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ACAP1 ANK3 INPP4B EEF1A1 AK5 SLC16A10	4.90e-05	194	149	6	e0ccf18edbae09fc1068f1e923f1bc0d0ff44195
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ACAP1 ANK3 INPP4B EEF1A1 AK5 SLC16A10	4.90e-05	194	149	6	fc0504730ae576ff46ba0bc9f585c53ab78d914c
ToppCell	Control-Lymphoid_T/NK-CD4+_T_naive\|Control / Disease group, lineage and cell class	ACAP1 ANK3 INPP4B EEF1A1 AK5 SLC16A10	4.90e-05	194	149	6	aabcd9f71d8ef54add5c46d8a3e226e3ae3ab124
ToppCell	COVID-19-lung-CD4+_T_cells_metabolically_active\|lung / Disease (COVID-19 only), tissue and cell type	ACAP1 ANK3 IQGAP2 DOCK8 INPP4B PCNX2	4.90e-05	194	149	6	2a144a1c2d537c8a59aa419206ddd96c23f0aeab
Drug	Ethambutol dihydrochloride [1070-11-7]; Up 200; 14.4uM; PC3; HT_HG-U133A	ZHX3 MAGEB2 SPTAN1 TDRD1 STAT2 ACSM3 HSD17B3 PCDH1 CDH6 ATP2B4	5.61e-07	197	145	10	4001_UP
Drug	Fusaric acid [536-69-6]; Up 200; 22.4uM; PC3; HT_HG-U133A	ZHX3 NAAA EPS8L1 STAT2 ACSM3 PTPRD PLXNC1 PCDH1 CDH6	4.78e-06	196	145	9	3986_UP
Drug	Tridihexethyl chloride; Up 200; 11.4uM; PC3; HT_HG-U133A	EPS8L1 TEX11 TDRD1 RYR2 KCTD17 ADGB KCTD14 SNRNP200 CXCR2	5.19e-06	198	145	9	5067_UP
Disease	obsolete_red blood cell distribution width	ATR DOCK8 NT5C3A ALG11 ECE1 ITGAX CRAT INPP4B KCTD17 NDUFV2 EEF1A1 EEF1A1P5 CSNK1G2 CSNK1G3 VPS13A HFM1 ATP2B3 ATP2B4 KNL1 SLC16A10 HELLS	3.53e-06	1347	147	21	EFO_0005192
Disease	4-hydroxyphenylacetylglutamine measurement	DNAH3 ACSM3	7.37e-05	3	147	2	EFO_0800688
Disease	developmental and epileptic encephalopathy 33 (implicated_via_orthology)	EEF1A1 EEF1A1P5	7.37e-05	3	147	2	DOID:0080463 (implicated_via_orthology)
Disease	Ovarian Failure, Premature	POF1B SOHLH2 HFM1	1.51e-04	21	147	3	C0085215
Disease	Macrothrombocytopenia	FLNA TRPM7	2.44e-04	5	147	2	C2751260
Disease	Hailey-Hailey disease (implicated_via_orthology)	ATP2B3 ATP2B4	3.65e-04	6	147	2	DOID:0050429 (implicated_via_orthology)
Disease	electroencephalogram measurement	DNAH3 CMYA5 PCNX2 PTPRD	5.19e-04	74	147	4	EFO_0004357
Disease	X-17676 measurement	DNAH3 ACSM3	6.77e-04	8	147	2	EFO_0800785
Disease	N-acylethanolamine-hydrolyzing acid amidase measurement	NAAA MYBPC1	8.67e-04	9	147	2	EFO_0008240
Disease	response to antineoplastic agent	RYR2 GHR TFCP2L1 PTPRD	1.54e-03	99	147	4	GO_0097327
Disease	Mood Disorders	ANK3 GSK3B TGFB1 VPS13A DLG4	1.57e-03	168	147	5	C0525045
Disease	advanced glycosylation end product-specific receptor, soluble measurement	FUT8 PRDM16	1.85e-03	13	147	2	EFO_0020131
Disease	response to trauma exposure	NT5C3A MYBPC1 DNAH11	2.12e-03	51	147	3	EFO_0008483
Disease	multiple myeloma, monoclonal gammopathy	SOHLH2 DNAH11	2.16e-03	14	147	2	EFO_0000203, EFO_0001378
Disease	orotic acid measurement	NT5C3A DNAH11	2.16e-03	14	147	2	EFO_0010516
Disease	susceptibility to bacterial meningitis measurement	CERKL ANK3 INPP4B	2.24e-03	52	147	3	EFO_0008411
Disease	reticulocyte measurement	FLNA ARHGEF28 ATR IQGAP2 ASH1L ITGAX BAZ1A AK5 VPS13A PRDM16 METAP2 ATP2B4 MYBPC1	2.40e-03	1053	147	13	EFO_0010700
Disease	third ventricle volume measurement	ANK3 PTPRD	2.48e-03	15	147	2	EFO_0010335
Disease	conotruncal heart malformations	INPP4B PTPRD PLXNC1 MDGA1	2.58e-03	114	147	4	MONDO_0016581
Disease	Hypertensive disease	ECE1 GSK3B TGFB1 ATP2B3 CXCR2	2.68e-03	190	147	5	C0020538
Disease	IGA glomerulonephritis	ITGAX TGFB1 FCRL3	3.06e-03	58	147	3	EFO_0004194
Disease	mean corpuscular hemoglobin concentration	ZHX3 ATR IQGAP2 NEB ECE1 KCTD17 BRDT BAZ1A VPS13A HFM1 PRDM16 ATP2B4 SLC16A10	3.62e-03	1105	147	13	EFO_0004528
Disease	Prostatic Neoplasms	ATR ASH1L GSK3B TGFB1 GHR ACSM3 EHHADH HSD17B3 TAF1L	3.84e-03	616	147	9	C0033578
Disease	Malignant neoplasm of prostate	ATR ASH1L GSK3B TGFB1 GHR ACSM3 EHHADH HSD17B3 TAF1L	3.84e-03	616	147	9	C0376358
Disease	osteochondrodysplasia (is_implicated_in)	FLNA TGFB1	3.99e-03	19	147	2	DOID:2256 (is_implicated_in)
Disease	diet measurement, HOMA-B	FAT3 PCNX2	3.99e-03	19	147	2	EFO_0004469, EFO_0008111
Disease	exercise test	RYR2 PTPRD	4.42e-03	20	147	2	EFO_0004328
Disease	response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement	PTPRD FUT8	4.42e-03	20	147	2	EFO_0803359, EFO_0803362
Disease	sleep measurement	ECE1 RYR2 IPO9 CDH6	4.73e-03	135	147	4	EFO_0004870
Disease	pelvic organ prolapse	CRAT PTPRD LOXL1 KCTD14	4.85e-03	136	147	4	EFO_0004710
Disease	Infiltrating duct carcinoma of female breast	ATR TRPM7	4.86e-03	21	147	2	C3165106

Protein segments in the cluster

Peptide	Gene	Start	Entry
YIPVKGEVCIAKYTV	TDRD1	311	Q9BXT4
QKKTFPEIIDYLYET	TTF1	816	Q15361
QLKEKYYAIEVDPVL	NT5C3A	126	Q9H0P0
LRALQKKYPEAVYVV	ALG11	86	Q2TAA5
VPLYKKIRSNVYVDV	ASH1L	2071	Q9NR48
IEKQILTGYYKTVEA	ASH1L	2496	Q9NR48
VDAVKLQLPDYYTII	BRDT	56	Q58F21
EQVPKVFQKVVPYLY	ADGB	1041	Q8N7X0
TEEVIEYFQKKVSPV	APOL4	36	Q9BPW4
SYKIVIEGKPYTVNL	ADAM2	46	Q99965
YIKKTYPLTQLVVVG	ABHD2	191	P08910
KLEKDYQPGITYIVV	AGO1	691	Q9UL18
SYSEPHYIKLQKVEV	AP4B1	321	Q9Y6B7
VIEDTELKQVAYIYK	CAP1	341	Q01518
ETKQTYECPVYRTKL	DNAH11	4471	Q96DT5
YEGVKYVLKVTRQSP	ACACA	676	Q13085
IVTLLDYVIEYTKKP	CRAT	351	P43155
DYVIEYTKKPELVRS	CRAT	356	P43155
KYESVNPYIVKLSIV	ARMH3	221	Q5T2E6
VYQKKYKDPVTVVVD	ACAP1	296	Q15027
KIPKYIVFVTNYPLT	ACSF2	581	Q96CM8
EKDYQPGITYIVVQK	AGO3	696	Q9H9G7
IIGYYAIDVKKVSVE	DIAPH3	981	Q9NSV4
VREQIPEDKLYKVYT	ATP2B3	561	Q16720
EVPEEKLYKVYTFNS	ATP2B4	556	P23634
KLVSKIQVPDYYDII	BAZ1A	1456	Q9NRL2
EADSKLKQVYIPTYT	MTA2	326	O94776
PHVQKYLKSVRYIEE	RALGPS1	256	Q5JS13
KTTFQLELPVKYAVY	ITGAX	911	P20702
LELPVKYAVYTVVSS	ITGAX	916	P20702
EKVVTLYPYTSQKDN	ABI3	311	Q9P2A4
YIIPAKSESEKYKVS	ARHGEF28	606	Q8N1W1
IYEPLYTQGETKVLK	MDGA1	186	Q8NFP4
VVVYAPLSKKQEIFY	HELLS	466	Q9NRZ9
LAETSYVKVLEYVIK	MAGEA1	271	P43355
YVKVLEYVIKVSARV	MAGEA1	276	P43355
DLVQEKYLEYKQVPS	MAGEB2	251	O15479
YEVEIDGKTYQVKPI	METAP2	311	P50579
LKDIIKEYTDVYPEI	MAGED2	306	Q9UNF1
LQVKIYDPTNKRYEV	MGAM2	1006	Q2M2H8
LLTAIYIYVVIPETK	SLC2A7	456	Q6PXP3
YIYVVIPETKGKTFV	SLC2A7	461	Q6PXP3
IPVIAYYETKTQLHK	AK5	526	Q9Y6K8
KLAKTPLIADVYYIV	NAAA	236	Q02083
KDKGIYVETIAEVYP	PHKA1	456	P46020
EYPIYEETKIKLTVY	INPP4B	101	O15327
LYTNEYVAIKLEPIK	CSNK1G2	66	P78368
PQIEKLLQSKYESYV	KATNB1	561	Q9BVA0
YILKVHVNPKYIVLE	LOXL1	531	Q08397
VQYPYEVGIKKEEEL	EHHADH	241	Q08426
PAVLYEAIQSFEKKV	PCNX2	1711	A6NKB5
IYEIKEETPVFYKLV	PLXNC1	416	O60486
NEEVALTEIYKYIVK	PLXNC1	1516	O60486
YFLQTTTPLDYEKVK	PCDH1	456	Q08174
TTPLDYEKVKDYTIE	PCDH1	461	Q08174
PESLEINKYFVVIIY	CXCR2	41	P25025
DYILKIVPTVYEDKS	ERGIC1	186	Q969X5
YPDFSVVVLYKKVII	KAT14	671	Q9H8E8
VKTPIQRAVQVYKYK	FAM47B	621	Q8NA70
DEVFTKVYKAKYPIV	NENF	126	Q9UMX5
EKALIETYQKEISPY	KNL1	1761	Q8NG31
FIVPSVVKDNTKYTY	KRIT1	111	O00522
HVYYTTIKNVEPKQE	PRDM10	306	Q9NQV6
KDYTVTQVPPKHVYR	KCTD17	131	Q8N5Z5
KNLYTNEYVAIKLEP	CSNK1G3	61	Q9Y6M4
VKLTTYPQTTIRKYV	POF1B	126	Q8WVV4
KIPTKENVYEAKSYE	PEG3	761	Q9GZU2
AFYVPAQYVKEVTRK	ARHGAP12	61	Q8IWW6
VLKKYTQYIIEVSAS	PTPRQ	861	Q9UMZ3
TQIKETVMYLPKYEL	HFM1	976	A2PYH4
TVMYLPKYELKVEQI	HFM1	981	A2PYH4
VISPYLETTKLIYKD	CFAP300	186	Q9BRQ4
ATIDKVVKIYDALIY	ATR	561	Q13535
VTYPSSDIYLVVKIE	DOCK8	336	Q8NF50
LKDLKPETEYVVNVY	COL12A1	1441	Q99715
ISSEKETVPFIQKIY	DNAH3	1221	Q8TD57
YEYVKLPIRTNISKE	GCNT4	276	Q9P109
PVYSLKVDKEYEVRV	GHR	216	P10912
VSYLLKDKGEYTLVV	FLNA	2616	P21333
KPYVSQISEYKLELA	FRMPD3	1651	Q5JV73
PYSQKRYEEIVKEVS	EEF1A1	161	P68104
VKEVSTYIKKIGYNP	EEF1A1	171	P68104
VLRPVYIGTVQYKIK	CMYA5	216	Q8N3K9
KCVLAEVPKQVVEYY	CPNE7	596	Q9UBL6
KVVSPLDYEVTSAYK	FAT3	2241	Q8TDW7
VPYTKLQLKELENEY	HOXD13	281	P35453
YSRAKQTLPVIYVKL	GSK3B	146	P49841
ESIYQPVPVKKYTFK	ANK3	3321	Q12955
EATQVYYEKVEPLLK	CERKL	181	Q49MI3
IVTTKKYRYQDEDTP	DLG4	6	P78352
YRKFYILDIEVTSKP	FCRL3	166	Q96P31
HYLVKVIAEKYPQLT	FMNL1	881	O95466
PYSQKRYEEIVKEVS	EEF1A1P5	161	Q5VTE0
VKEVSTYIKKIGYNP	EEF1A1P5	171	Q5VTE0
EAAYPEIVAVYQKQK	GEN1	446	Q17RS7
STVKKALPELIYYII	IPO9	351	Q96P70
KVYTLKVEASNPYVE	CDH6	341	P55285
PIVVYDKEYLEQIST	ECE1	366	P42892
SEAKPSQYYELQVLK	FAM186A	486	A6NE01
PVELKEYLKINDTIY	HELQ	521	Q8TDG4
PSEAEYTDVLQKIKY	EPS8L1	311	Q8TE68
YKAKEVIIQVLTPYA	HSD17B3	216	P37058
EVIKQEYQKLGPIRY	SLC13A1	331	Q9BZW2
ITIPEKLEYFINKYA	RYR2	2711	Q92736
QVYPVEEALLKEYIK	LARP1B	206	Q659C4
SDLIYKLYVVQTVIK	LRRC8D	301	Q7L1W4
VSYYIIQHKPKNSEE	PTPRD	351	P23468
PIIYGVKTKQIREYV	OR52K1	291	Q8NGK4
YKVREKIETVKYPTY	FUT8	556	Q9BYC5
LIFSVPIVYEKYKTQ	RTN3	986	O95197
YYNLKDLVDITKQPV	GTF2F2	196	P13984
LIYEDYVSILSPKEV	RGS19	141	P49795
DKVLIYSVQPYTKEV	STAT2	621	P52630
TPVNAKVVKDYYKII	TAF1L	1426	Q8IZX4
KYTDLVTVSKPVIYI	IQGAP2	1196	Q13576
PDIVKSEYLQYSLTK	MTERF4	246	Q7Z6M4
QIYYKVIKDIEPGEE	PRDM16	191	Q9HAZ2
QTKPDYLEVLEKTTY	SLITRK3	961	O94933
IFQIPRTKTYEKVDE	PKD1L3	1366	Q7Z443
YYVLQFLKEDLPKVV	POLR3A	1186	O14802
VVTYKEDFVPNTEKI	SMIM26	66	A0A096LP01
YTDIKDYLAQPEKIT	NUDT12	181	Q9BQG2
PYFRNEVLVKTYIIK	NAP1L3	366	Q99457
PITLTVKYDVAYTVL	OCSTAMP	341	Q9BR26
SELEKVLPQTILYKY	RNF216	571	Q9NWF9
FETVKYYLLSQEPEK	WDR17	1096	Q8IZU2
KVLANQYKSIYPTLE	ADSS2	196	P30520
VYREAQFYEIKPLVK	KCTD14	106	Q9BQ13
EKEKYQPSYETTILT	TFCP2L1	241	Q9NZI6
SKDKAPYLIYVEVLE	PI4KB	391	Q9UBF8
EIQEHVKKTTAPYKY	ACSM3	541	Q53FZ2
LESETTNKYIYPLVK	CFAP210	481	Q0VFZ6
SKSEYLIPKQETYDQ	CLCA3P	86	Q9Y6N3
VPLKIEKEAIVYYVA	LINC00615	91	Q96LM1
YRVPVLLEEQSIVKY	CTPS2	251	Q9NRF8
EENYKVPEYKTVISF	VPS13A	1821	Q96RL7
YPRIQSIKVQFTEYK	TNFSF4	56	P23510
VIPNEESVVIYYKIR	MTREX	616	P42285
VSVFDAYVLPKLYVK	RPS26P11	56	Q5JNZ5
EKEKYQPSYETTILT	TFCP2	261	Q12800
RAVEEVKLAIKPYYQ	SCAF1	1216	Q9H7N4
ETINKYAFIKNEYPV	PLCH2	401	O75038
QVSVKPTLYIIKYDG	SPIN4	66	Q56A73
KPYVTKEELYQNLTR	SPTAN1	2421	Q13813
IVYYVGRKPKVEQLS	TGFB1	366	P01137
LQKTKTIEYLTIIVY	SPANXN2	41	Q5MJ10
LLYKKEEPIDISQYS	TEX11	801	Q8IYF3
IYKPKTKETRETYEV	SNRNP200	101	O75643
VDYVKYIREKISPAV	SOHLH2	246	Q9NX45
KAELCYLTVVTKYPE	ZHX3	331	Q9H4I2
YLTVVTKYPEEQLKI	ZHX3	336	Q9H4I2
VLPVGVLYKVKVYET	PTS	121	Q03393
AKYVRLSYDTKPEVI	TRPM7	106	Q96QT4
VEHVVSVLEKKYPYV	UGGT1	586	Q9NYU2
SVLEKKYPYVEVNSI	UGGT1	591	Q9NYU2
YDKLFPQNSVIIEYK	ZNF527	196	Q8NB42
DYVPGVKKVYLQVLS	SLC16A10	351	Q8TF71
KIYSSYPKVQETLPV	MXRA5	1301	Q9NR99
KVIPTSSEKYQIYQD	MXRA5	2386	Q9NR99
PKYYSQPILVKEIIE	MYBPC1	821	Q00872
TPENYKRIEAIVKNY	NDUFV2	56	P19404
KYKVVLDTPEYRKVQ	NEB	5136	P20929